ArticleThe journal of vascular access2026
Implementation of electronic patient-reported outcome measures in hemodialysis: Findings from a matched cohort study.
Article in The journal of vascular access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntegrating electronic patient-reported outcome measures (ePROMs) into routine hemodialysis (HD) care offers a way to enhance patient-centered decision-making.
methodsThis prospective matched cohort study involved adults on in-center HD followed for 6 months. The intervention group completed monthly ePROMs (SF-VAQ and SF-36v2), while the control group received standard care. Outcomes included changes from baseline in Vascular Access (VA) related interventions, hospitalizations, SF-VAQ domain scores, and Health-Related Quality of Life (HRQoL).
resultsIntegrating ePROMs did not significantly impact the frequency of VA-related interventions or hospitalizations during the study period. Significant improvements were observed in the SF-VAQ domains, including reductions in perceived VA-related burden in the Physical (
conclusionsImplementation of an ePROM-guided care pathway is feasible and associated with improved patient-reported well-being and reduced VA-related burden. While these results suggest a benefit, the absence of longitudinal process data in the control arm means further research is required to distinguish ePROM-induced changes from standard care evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.